Ventricular conduction is a marker for arrhythmic risk in SCN5A- E1784K overlap sodium channel disease
Europace · 02.06.2026 · 28 (6)
DOI: 10.1093/europace/euag113 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Europace, online erschienen am 11.05.2026. Verfasst von Michael W T Tanck und 36 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, University of Amsterdam, Epidemiology and Data Science, Amsterdam Public Health, Meibergdreef 9, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: Brugada Syndrome, Heart Conduction System, Long QT Syndrome, NAV1.5 Voltage-Gated Sodium Channel. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: James Lancaster Memorial Fund, McColl's RG Ltd, National Institute of Health Research.
Abstract (Originalsprache)
Aims
SCN5A-E1784K (c.5350G>A) is the most common variant associated with the long QT (LQTS) and Brugada syndromes (BrS). It can manifest variably as LQTS, BrS, and/or conduction disorders. This presents a challenge for risk stratification. We aimed to describe clinical and ECG characteristics and identify risk markers that associate with arrhythmic events. Methods and results We undertook a retrospective observational multicentre study of a large cohort of 231 subjects with SCN5A-E1784K from Europe, USA, and Japan. Comprehensive demographic and clinical data, including initial presentation ECG and follow-up, were collected. ‘Lethal events’ were defined as sudden death, non-fatal cardiac arrest, and documented sustained VT or VF. ‘Cardiac events’ were defined as arrhythmic syncope plus any lethal events. Clinical characteristics and ECG parameters corrected for age were investigated for association with lethal and/or cardiac events. Fourteen (6%) subjects experienced a lethal event and 45 (19%) a cardiac event. PR interval and QRS duration were associated with lethal and cardiac events. In multivariable models, both PR interval and QRS duration were associated with lethal events, but only QRS duration was associated with cardiac events. Only age-corrected QRS (rQRS) was associated with lethal and cardiac event-free survival from birth after correction for multiple testing.
Conclusion
Ventricular myocardial conduction appears likely to play a role in the risk of arrhythmic events in patients with SCN5A-E1784K. This provides an important opportunity for the personalization of management and has the potential to guide preventative therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam UMC, University of Amsterdam, Epidemiology and Data Science, Amsterdam Public Health, Meibergdreef 9, Amsterdam, Netherlands.
- Cardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London SW17 0RE, UK.
- St George's University Hospitals National Health Service (NHS) Foundation Trust, London, UK.
- Department of Medical Genetics, Nantes Université, CNRS, INSERM, L'institut du Thorax, Nantes F-44000, France.
- Belfast Health and Social Care Trust, Belfast, UK.
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
ORCID-Profile: Michael W T Tanck, Yanushi D Wijeyeratne, Julien Barc, Takeshi Aiba, J Martijn Bos, Christian Veltmann, Joseph Galvin, Lia Crotti, Taisuke Ishikawa, Seiko Ohno, Isabelle Denjoy, Kazuhiro Takahashi, Hariharan Raju, Jean Baptiste Gourraud, Richard Redon, Jean-Jacques Schott, Matteo Pedrazzini, Chiara Alberio, Federica Dagradi, Michael Papadakis, Sanjay Sharma, Edward Petzer, Dan M Roden, Minoru Horie, Peter J Schwartz, Naomasa Makita, Martin M Borggrefe, Wataru Shimizu, Vincent Probst, Elijah R Behr
Förderung
- James Lancaster Memorial Fund
- McColl's RG Ltd
- National Institute of Health Research
- Higher Education Funding Council for England
- British Heart Foundation
- Medical Research Council
- Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program
- ANR JCJC
Zitieren
APA
Tanck, M. W. T., Wijeyeratne, Y. D., Barc, J., Muir, A., Aiba, T., Bos, J. M., Veltmann, C., Galvin, J., Crotti, L., Ishikawa, T., Ohno, S., Page, S. P., Denjoy, I., Tester, D. J., Muggenthaler, M., Takahashi, K., Raju, H., Gourraud, J. B., Redon, R., …, & Behr, E. R. (2026). Ventricular conduction is a marker for arrhythmic risk in SCN5A- E1784K overlap sodium channel disease. Europace, 28(6). https://doi.org/10.1093/europace/euag113
Vancouver
Tanck MWT, Wijeyeratne YD, Barc J, Muir A, Aiba T, Bos JM, et al. Ventricular conduction is a marker for arrhythmic risk in SCN5A- E1784K overlap sodium channel disease. Europace. 2026;28(6). doi:10.1093/europace/euag113
BibTeX
@article{Tanck2026,
author = {Tanck, Michael W T and Wijeyeratne, Yanushi D and Barc, Julien and Muir, Alison and Aiba, Takeshi and Bos, J Martijn and Veltmann, Christian and Galvin, Joseph and Crotti, Lia and Ishikawa, Taisuke and Ohno, Seiko and Page, Stephen P and Denjoy, Isabelle and Tester, David J and Muggenthaler, Martina and Takahashi, Kazuhiro and Raju, Hariharan and Gourraud, Jean Baptiste and Redon, Richard and Schott, Jean-Jacques and Haglund-Turnquist, Carla and Pedrazzini, Matteo and Alberio, Chiara and Dagradi, Federica and Papadakis, Michael and Sharma, Sanjay and Petzer, Edward and Roden, Dan M and Horie, Minoru and Schwartz, Peter J and Makita, Naomasa and Borggrefe, Martin M and Ackerman, Michael J and Shimizu, Wataru and McKeown, Pascal P and Probst, Vincent and Behr, Elijah R},
title = {Ventricular conduction is a marker for arrhythmic risk in SCN5A- E1784K overlap sodium channel disease},
journal = {Europace},
year = {2026},
volume = {28},
number = {6},
doi = {10.1093/europace/euag113}
}
EUVIMED